Corpus ID: 38495448

Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.

@article{Halperin2001ComparativeIS,
  title={Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.},
  author={R. Halperin and S. Zehavi and L. Habler and E. Hadas and I. Bukovsky and D. Schneider},
  journal={European journal of gynaecological oncology},
  year={2001},
  volume={22 2},
  pages={
          122-6
        }
}
OBJECTIVE The aim of this study was to determine whether immunohistochemical analysis of molecular parameters can provide an alternative method for classification of endometrial cancer cases according to their aggressiveness. METHODS Sixty-four cases of endometrial carcinoma were assigned to three groups: group I--28 cases of endometrioid well and moderately differentiated (G1-G2) carcinoma; group II--14 cases of endometrioid poorly differentiated (G3) carcinoma; group III--22 cases of serous… Expand
High-Grade Endometrial Carcinoma: Serous and Grade 3 Endometrioid Carcinomas Have Different Immunophenotypes and Outcomes
  • A. AlKushi, M. Köbel, S. Kalloger, C. Gilks
  • Medicine, Biology
  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2010
TLDR
EC-3 carcinomas have a significantly better prognosis than SC carcinomas of the endometrium, and are superior to ER, PR, and p53 for this purpose. Expand
A study of expression of estrogen and progesterone receptor, in atrophic, hyperplastic and malignant endometrial lesions, with emphasis on relationship with prognostic parameters
Background: Aims of current study were to study the expression of estrogen receptor (ER) and progesterone receptor (PR) in atrophic, hyperplastic and malignant endometrial tissue, usingExpand
Selected Immunohistochemical Prognostic Factors in Endometrial Cancer
TLDR
The overexpression of p53 and Ki-67 seems to indicate a more malignant phenotype, whereas bcl-2 expression in dependence of steroid receptor positivity could contribute to the identification of high-risk tumors. Expand
Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer.
TLDR
Identification of p53, Ki 67, c-erbB-2, PR and determination of DNA ploidy is a useful tool to specify a group of prognostically unfavourable patients. Expand
Prognostic biomarkers in endometrial adenocarcinoma.
TLDR
The study shows the importance of the use of biomarkers in the positive diagnosis and the guiding of therapeutic approach in endometrial carcinoma and observed a correlation between p53 overexpression and specific histological alterations. Expand
Histomorphology and Role of Immunohistochemistry in Endometrial Carcinomas
TLDR
The immunohistochemical study of ER, PR and p53 and its significance on the prognosis are few in literature when compared to breast carcinoma. Expand
The Significance of p53 and Estrogen Expression in Endometrial Hyperplasias and Endometrioid Carcinomas: How should we evaluate immunohistochemistry?
TLDR
Most EC cases have a higher p53 but lower ER expression, which can be used as an indicator of tumour aggressiveness, and first glance importance should be given to epithelial expression of p53 and stromal expression of ER. Expand
Selected Immuno-Histochemical Markers in Curettage Specimens and their Correlation with Final Pathologic Findings in Endometrial Cancer Patients
To assess the immuno-histochemical expression of various markers in, endometrial biopsies of patients with endometrial cancer, and to correlate their expression with the final pathologic findings.Expand
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
TLDR
In patients with serous adenocarcinoma of the endometrium, established clinicopathological parameters do not seem to be strong prognosticators in stage I and II disease, and a DNA ploidy parameter may be a prognostic marker in this patient group and should be further validated in larger series. Expand
The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma
Endometrial adenocarcinoma is the most common pelvic genital malignancy in the western world. The most common subtype of endometrial cancer is endometrioid endometrial carcinoma (EEC), which has aExpand
...
1
2
3
4
5
...